Clinical Trial: A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes

U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07357740) titled 'A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes' on Jan. 21.

Brief Summary: This study is being done to look at how well a study medicine called CagriSema helps people with diabetes lower their blood sugar. In this study the sponsor will compare two version of CagriSema injected by two different types of injection devices. Which treatment participants get is decided by chance. CagriSema is still being tested in studies and is not yet available for doctors to prescribe. The study will last for about 38 weeks.

Study Start Date: Aug. 27, 2026

Study Type: INTERVENTIONAL

Condit...